Inventor · disambiguated record
Thomas Thisted
Also filed as: ANDERSEN CARSTEN · THISTED THOMAS
33 granted patents·25 pending applications·296 citations·filing 2001–2025
97Inventor score
Top patents by PatentIndex Score
58 records- 0198US7713723B1Alpha-amylase mutants with altered propertiesNOVOZYMES AS·Filed 2009·Granted May 11, 2010·70 cites·17 claims
- 0297US7498158B2Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2002·Granted Mar 3, 2009·65 cites·26 claims
- 0395US10287576B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2016·Granted May 14, 2019·19 cites·22 claims
- 0493US7727713B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2002·Granted Jun 1, 2010·39 cites·241 claims
- 0591US8617837B2Method of hydrolyzing soluble starch with an alpha-amylase variantSVENDSEN ALLAN·Filed 2012·Granted Dec 31, 2013·5 cites·4 claims
- 0690US7611882B2Detergent compositions comprising Bacillus subtilis pectate lyasesNOVOZYMES AS·Filed 2002·Granted Nov 3, 2009·29 cites·9 claims
- 0788US9574189B2Enzymatic encoding methods for efficient synthesis of large librariesFRANCH THOMAS·Filed 2006·Granted Feb 21, 2017·19 cites·38 claims
- 0888US8252573B2Alpha-amylase variant with altered propertiesSVENDSEN ALLAN·Filed 2011·Granted Aug 28, 2012·3 cites·1 claims
- 0987US9005950B2Pectate lyase variantsNOVOZYMES AS·Filed 2013·Granted Apr 14, 2015·5 cites·18 claims
- 1085US10669538B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2016·Granted Jun 2, 2020·2 cites·106 claims
- 1185US8932992B2Templated molecules and methods for using such moleculesPEDERSEN HENRIK·Filed 2008·Granted Jan 13, 2015·6 cites·11 claims
- 1284US8563290B2Pectate lyase variantsGLAD SANNE SCHRODER·Filed 2012·Granted Oct 22, 2013·4 cites·12 claims
- 1384US7601529B2Pectate lyase variantsNOVOZYMES AS·Filed 2003·Granted Oct 13, 2009·8 cites·30 claims
- 1483US10000553B2CD40L-specific TN3-derived scaffolds and methods of use thereofMEDIMMUNE LLC·Filed 2012·Granted Jun 19, 2018·6 cites·19 claims
- 1583US8288144B2Pectate lyase variantsGLAD SANNE SCHRODER·Filed 2009·Granted Oct 16, 2012·4 cites·20 claims
- 1682US9080137B2Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2013·Granted Jul 14, 2015·1 cites·18 claims
- 1781US10612012B2Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2019·Granted Apr 7, 2020·0 cites·19 claims
- 1880US2015099284A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2014·Application pending·0 cites
- 1978US9096951B2Method for producing second-generation libraryFRESKGARD PER-OLA·Filed 2011·Granted Aug 4, 2015·2 cites·12 claims
- 2078US2023242619A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2022·Application pending·0 cites
- 2177US11104720B2Nucleic acids encoding a Tn3 scaffold comprising a CD40L-specific monomer subunitVIELA BIO INC·Filed 2018·Granted Aug 31, 2021·1 cites·22 claims
- 2274US11597916B2Nicotine degrading enzyme variantsANTIDOTE THERAPEUTICS INC·Filed 2018·Granted Mar 7, 2023·1 cites·24 claims
- 2374US11555062B2Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomerVIELA BIO INC·Filed 2021·Granted Jan 17, 2023·0 cites·39 claims
- 2474US9670471B2Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2014·Granted Jun 6, 2017·0 cites·19 claims
- 2574US9101565B2Dissolution stability of calcium carbonate tabletsOLSEN PEDER MOHR·Filed 2009·Granted Aug 11, 2015·2 cites·3 claims
- 2674US8486681B2Alpha-amylase variant with altered propertiesSVENDSEN ALLAN·Filed 2009·Granted Jul 16, 2013·1 cites·25 claims
- 2772US11440970B2Nicotine-binding antibodiesANTIDOTE THERAPEUTICS INC·Filed 2018·Granted Sep 13, 2022·1 cites·18 claims
- 2872US2020181593A1Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2020·Application pending·0 cites
- 2972US2025257120A1Compositions comprising a tn3 scaffold and methods of using the sameVIELA BIO INC·Filed 2025·Application pending·0 cites
- 3071US2017166876A1Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2017·Application pending·0 cites
- 3169US11702652B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2020·Granted Jul 18, 2023·0 cites·21 claims
- 3269US9796968B2Alpha-amylase variant with altered propertiesNOVOZYMES AS·Filed 2015·Granted Oct 24, 2017·0 cites·18 claims
- 3368US2010022433A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2009·Application pending·0 cites
- 3467US11965209B2Method for obtaining structural information concerning an encoded molecule and method for selecting compoundsNUEVOLUTION AS·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 3567US11118215B2Method for obtaining structural information concerning an encoded molecule and method for selecting compoundsTHISTED THOMAS·Filed 2004·Granted Sep 14, 2021·2 cites·141 claims
- 3667US2016312201A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2016·Application pending·0 cites
- 3767US2023416697A1Novel nicotine degrading enzyme variantsANTIDOTE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3867US2019330618A1Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2019·Application pending·0 cites
- 3967US2013203124A1Alpha-Amylase Variant With Altered PropertiesNOVOZYMES AS·Filed 2012·Application pending·0 cites
- 4066US9212231B2TRAIL R2-specific multimeric scaffoldsBACA MANUEL·Filed 2011·Granted Dec 15, 2015·1 cites·24 claims
- 4166US2014030767A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2013·Application pending·0 cites
- 4265US9688980B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2014·Granted Jun 27, 2017·0 cites·14 claims
- 4362US2007026397A1Method for producing second-generation libraryNUEVOLUTION AS·Filed 2004·Application pending·0 cites
- 4461US2011171694A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2011·Application pending·0 cites
- 4559US2010190681A1Alpha-Amylase Mutants with Altered PropertiesNOVOZYMES AS·Filed 2010·Application pending·0 cites
- 4659US2023089068A1Novel nicotine-binding antibodiesANTIDOTE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4755US2023272082A1Anti-vista antibodies and uses thereofSENSEI BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4852US2005250663A1Alpha-amylase mutants with altered propertiesNOVOZYMES AS·Filed 2003·Application pending·0 cites
- 4951US2005176948A1Building block capable of functional entity transfer to nucleophilFiled 2003·Application pending·0 cites
- 5050US12318433B2Nicotine degrading enzyme variantsANTIDOTE THERAPEUTICS INC·Filed 2019·Granted Jun 3, 2025·0 cites·27 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Thomas Thisted files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →